Complete Sequence of the 23-Kilobase Human COL9A3Gene: DETECTION OF GLY-X-Y TRIPLET DELETIONS THAT REPRESENT NEUTRAL VARIANTS
petteri paassilta,tero pihlajamaa,susanna annunen,randolph g brewton,B M Wood,cameron c johnson,jiangang liu,yaoqin gong,matthew l warman,darwin j prockop,richard mayne,leena alakokko
DOI: https://doi.org/10.1074/jbc.274.32.22469
IF: 5.485
1999-01-01
Journal of Biological Chemistry
Abstract:We report the complete sequence of the human COL9A3 gene that encodes the alpha 3 chain of heterotrimeric type IX collagen, a member of the fibril-associated collagens with interrupted triple helices family of collagenous proteins. Nucleotide sequencing defined over 23,000 base pairs (bp) of the gene and about 3000 bp of the 5'-flanking sequences. The gene contains 32 exons, The domain and exon organization of the gene is almost identical to a related gene, the human COL9A2 gene. However, exon 2 of the COL9A3 gene codes for one -Gly-X-Y- triplet less than exon 2 of the COL9A2 gene. The difference is compensated by an insertion of 9 bp coding for an additional triplet in exon 4 of the COL9A3 gene. As a result, the number of -Gly-X-Y- repeats in the third collagenous domain remains the same in both genes and ensures the formation of an in-register triple helix. In the course of screening this gene for mutations, heterozygosity for separate 9-bp deletions within the COL1 domain were identified in two kindreds, In both instances, the deletions did not co-segregate with any disease phenotype, suggesting that they were neutral variants, In contrast, similar deletions in triple helical domain of type I collagen are lethal, To study whether alpha 3(IX) chains with the deletion will participate in the formation of correctly folded heterotrimeric type IX collagen, we expressed mutant alpha 3 chains together with normal alpha 1 and alpha 2 chains in insect cells, We show here that despite the deletion, mutant alpha 3 chains were secreted as heterotrimeric, triple helical molecules consisting of three alpha chains in a 1:1:1 ratio. The results suggest that the next noncollagenous domain (NC2) is capable of correcting the alignment of the alpha chains, and this ensures the formation of an in-register triple helix.